PRL secreting pituitary adenomas, also known as prolactinomas, are non-cancerous tumors that develop in the pituitary gland of the brain and primarily secrete excessive amounts of the hormone prolactin. These adenomas are the most common type of pituitary tumor and are usually classified as benign, as they do not spread to other parts of the body.
The pituitary gland, located at the base of the brain, is responsible for producing and releasing various hormones that regulate numerous bodily functions. Prolactinoma occurs when the cells in the pituitary gland that produce prolactin undergo uncontrolled growth, leading to the development of a tumor. This tumor often results in excessive production and release of prolactin, leading to abnormally high levels of the hormone in the blood.
This condition can affect both men and women, but it is more commonly observed in women. Prolactinomas can cause a range of symptoms, including irregular menstrual periods, breast milk production (even in individuals who are not pregnant or nursing), infertility, decreased libido, and a variety of visual disturbances due to the pressure exerted on the optic nerves by the growing tumor.
PRL secreting pituitary adenomas can be effectively managed with various treatment options, including medication to regulate prolactin levels, surgical removal of the tumor, and radiation therapy in certain cases. Treatment decisions are based on factors such as the size and location of the tumor, the severity of symptoms, and the patient's overall health.
Regular monitoring and follow-up care are important to manage the condition and prevent potential complications, such as the tumor growing larger or causing damage to surrounding structures in the brain.
